Diabetes and its treatment impact prognosis in patients with breast cancer
the ONA take:
Pre-existing diabetes increases risk of total mortality among women with breast cancer. This conclusion comes from a study that assessed the impact of pre-existing diabetes and diabetes treatment on prognosis for patients with breast cancer.
Researchers followed 8,108 women in the Women’s Health Initiative with centrally confirmed breast cancer diagnosed between 1998 an 2013. The women were followed through the date of death or September 20, 2013. Self-reports and face-to-face reviews of current medication containers were used to gather information on the patients’ diabetes and diabetes treatment.
The study showed that risk of overall mortality, among those who took insulin or had longer duration of diabetes in particular, was higher in women with diabetes compared with those who did not have diabetes. However, the disease was not associated with breast cancer-specific mortality regardless of treatment or duration.
This study demonstrates that increased mortality in patients with diabetes is more closely associated with greater risk of dying from diseases other than breast cancer; thus, careful attention to cardiovascular risk factors and other noncancer conditions should be a significant part of the continuum of care for patients with breast cancer.
Pre-existing diabetes increases risk of total mortality among women with breast cancer.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Prolactin Expression May Indicate Better Prognosis for Patients With TNBC
- Caregiver Mastery Linked to Patient Survival in Glioblastoma
- Treatment Facility Volume Associated With Mortality Risk in Multiple Myeloma
- Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|